Resource Center
Find the latest content and resources from our team of experts to keep you in the know for all things quality and regulatory in the life science industry.
Sort by topic
Sort by resource type
EMA Explores New Biomarkers and Patient Populations in Proposed Parkinson’s Disease Guideline Update
The European Medicines Agency (EMA) has released a concept paper outlining proposed updates for its clinical ...
EMMA International is proud to announce that it has been awarded the EurAsia Gulf Excellence Award. This ...
The U.S. Food and Drug Administration (FDA) has released new draft guidance that could significantly reduce the ...
More than five years after ranitidine products were withdrawn due to concerns about nitrosamine contamination, a ...
A sharp rise in enforcement actions has defined fiscal year 2025 for the Center for Drug Evaluation and Research ...
Emma International is proud to announce the launch of its GCC Services division. This expansion strengthens EMMA ...
As the FDA prepares to implement the long-anticipated Quality Management System Regulation (QMSR)—set to take ...
The U.S. Food and Drug Administration (FDA) is expanding the use of real-time review programs, allowing regulators ...
During the 2025 Combination Products Summit in Providence, RI, leadership from the FDA’s Office of Combination ...
The U.S. Food and Drug Administration (FDA) has issued an untitled letter to AstraZeneca regarding a television ...
Influencer-driven marketing has become one of the most powerful forces in the food supplement industry, ...
The US Food and Drug Administration (FDA) is receiving significant feedback from industry, patient groups, and ...
No results found.